S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00124579 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

NETWORK

Sponsor class

Stopped poor accrual

Conditions

Multiple Myeloma

Interventions

DRUG: bortezomib
DRUG: dexamethasone
DRUG: thalidomide

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]